The Health Resources & Services Administration recently posted 340B Drug Pricing Program ceiling prices to help covered entities identify the maximum prices pharmaceutical companies can charge for 340B Program drugs. Read on for details.
The Centers for Medicare & Medicaid Services (CMS) calendar year 2018 Outpatient Prospective Payment System rule will result in additional reimbursement cuts for 340B Drug Pricing Program-covered entities. Read on for details.
The Centers for Medicare & Medicaid Services recently issued a final rule that continues the transition for using uncompensated care cost data on Worksheet S-10 to distribute uncompensated care payments. In addition, Worksheet S-10 audits have…
A new Centers for Medicare & Medicaid Services (CMS) proposed rule proposes updates to policies including the skilled nursing facility (SNF) Value-Based Purchasing (VBP) program year, scoring methodology and more. Read on for details.